Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)

CUSIP: 87978U207

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
13,473,733
Total 13F shares
517,764
Share change
+201,712
Total reported value
$1,485,974
Price per share
$2.87
Number of holders
19
Value change
+$539,434
Number of buys
8
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 87978U207?
CUSIP 87978U207 identifies TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) as of Q4 2025

As of 31 Dec 2025, Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 517,764 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., FMR LLC, UBS Group AG, NORTHERN TRUST CORP, DIMENSIONAL FUND ADVISORS LP, DRW Securities, LLC, and MORGAN STANLEY. This page lists 19 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.